Purchase Order 36C26121P0796
Award Date 4/6/21
Potential Completion Date 9/30/21
Potential Value $82K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Palo Alto, CA 94304, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company. The contract, valued at $94,899.21, is for the delivery of the drug Tyvaso, which is used to treat pulmonary arterial hypertension. The contract is not associated with a larger contract vehicle and does not have a set-aside designation. Accredo Health Group, Inc. is the prime contractor and there are no major...
- This is a $93,341.96 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company. The contract is for the specialty pharmaceutical Tyvaso, which is used to treat pulmonary arterial hypertension. This contract is part of Accredo Health Group's ongoing work supporting the VA's Veterans Integrated Service Network (VISN) 21 with the distribution of specialty medications. The...
- The U.S. Department of Veterans Affairs (VA) awarded a $81,342.18 firm fixed-price purchase order contract to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, to provide the specialty pharmaceutical TYVASO. The contract, which does not have a set-aside designation, is to support the VA's Veterans Integrated Service Network 21 (VISN 21) and has an ultimate completion date of September 30, 2022. Accredo Health Group, Inc. is a key distributor of complex and...
- This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 21 to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, for the delivery of the specialty pharmaceutical Tyvaso. The total ceiling value of the contract is $81,342.18, with a period of performance through September 30, 2022. Accredo Health Group, Inc. is a key distributor of complex and high-value medications, primarily serving the...
- This is a $113,770.56 firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company. The contract is for the delivery of TYVASCO 0.6 MG, a specialty pharmaceutical product, to support veterans' healthcare through the VA's Veterans Integrated Service Network 21. The contract does not have a set-aside designation and will be performed at Accredo's...
- This is a firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company that specializes in specialty pharmaceutical services. The contract, valued at $75,576.09, is for the delivery of Uptravi medicine to support the VA's Veterans Integrated Service Network (VISN) 6. The contract does not have a set-aside designation and was awarded on October 27, 2020, with a completion date of...
- This is a $103,003.20 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company specializing in specialty pharmaceutical services. The contract is for the delivery of various complex and high-value medications, primarily to support the VA's Veterans Integrated Service Network (VISN) healthcare facilities. Key medications provided under this contract include drugs used to treat...
- This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company specializing in specialty pharmaceutical services. The contract, valued at $160,429.83, is for the delivery of the medication Uptravi 1600mcg, which is used to treat pulmonary arterial hypertension (PAH). The contract is part of the VA's efforts to provide critical medications to veterans through its Veterans...
- This firm fixed-price purchase order was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 16 to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, to provide the specialty pharmaceutical drug Uptravi-Selexipag. The $144,743.29 contract has a completion date of March 17, 2022 and supports the VHA's distribution of critical medications to treat pulmonary arterial hypertension for patients and...
- Accredo Health Group, Inc. was awarded a firm fixed price purchase order without set-aside by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21. The order is for the delivery of TYVASO to the Palo Alto, California location, with a potential value of $47,594.01 and completion by May 22, 2023. As a prime contractor supporting the VA through its national pharmaceutical contracts, Accredo Health Group will distribute this specialized pulmonary...